Home » Author Archives: tifwp (page 12)

Author Archives: tifwp

Indonesia 2016

TIF Medical Advisors, Dr Michael Angastiniotis and Prof Suthat Fucharoen, were invited by the Indonesian Haematology Society to its annual conference, in order to present aspects of thalassaemia control. The opportunity was taken to review the current situation in the country as far as services for thalassaemia are concerned. In ...

Read More »

India 2016

India was visited for the second time in 2016 on the occasion of the 8th National Conference on thalassaemia on the 17th and 18th of December. The conference was organised by the National Thalassaemia Welfare Society and the haematology Department of the All India Institute of Medical Science (AIIMS). Representing ...

Read More »

Cyprus 2016

On the 29 November 2016, the Pan-Cyprian Association held a conference in Limassol for its members, with talks from TIF and from EOTHA (Greece). On 16 January, TIF president Mr Panos Englezos, Executive Director Dr Androulla Eleftheriou and Dr Michael Angastiniotis visited the Turkish Cypriot Thalassaemia centre on the occasion ...

Read More »

Mr Panos Englezos – President

Mr Panos Englezos is a graduate of London University in Economics and Accounting. He is the Chairman and Chief Executive of a group of companies which he established in 1961. The birth of his son, George, with β-thalassaemia major led to his deep lifelong involvement in the development and promotion ...

Read More »

Mr George Constantinou

Mr George Constantinou, obtained a degree in Hotel and Tourism studies in London and has had a long and successful professional career. His contribution, passion, and undivided commitment to improving the health and quality of life of patients with thalassaemia are exemplary. Since the early years, he has been involved ...

Read More »

Mr Riyad Elbard

Mr Riyad Elbard, President of Thalassemia Foundation of Canada, has been a leading member of the Thalassemia Foundation of Canada for over 15 years. He is dedicated to advocating for optimal care for all thalassemia patients. He represents the foundation on various committees and has been instrumental in building and ...

Read More »